COVID-19 infection in Crohn's disease under treatment with adalimumab

被引：41
|
作者：
Tursi, Antonio [1 ]
Angarano, Gioacchino [2 ]
Monno, Laura [2 ]
Saracino, Annalisa [2 ]
Signorile, Fabio [2 ]
Ricciardi, Aurelia [2 ]
Papa, Alfredo [3 ]
机构：
[1] Azienda Sanit Locale Barletta Andria Trani, Gastroenterol Serv, Andria, Puglia, Italy
[2] Univ Bari, Bari Univ Hosp, Div Infect Dis, Bari, Puglia, Italy
[3] Univ Cattolica Sacro Cuore, Fac Med & Surg, Div Internal Med & Gastroenterol, Complesso Integrato Columbus, Rome, Lazio, Italy
来源：
GUT | 2020年 / 69卷 / 07期
关键词：
crohn's disease; immune response;
D O I：
10.1136/gutjnl-2020-321240
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1364 / +
页数：2
相关论文
共 50 条
  • [21] Adalimumab in Crohn's disease
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 355 - 365
  • [22] Adalimumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [23] Favorable outcome of COVID-19 in a young woman with severe Crohn's disease on regular use of adalimumab and prednisone: a case report
    Vechi, Hareton Teixeira
    Maia, Lucas Rodrigues
    Alves, Manoela Monte
    Rodrigues-Neto, Joao Firmino
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2020, 62
  • [24] Adalimumab - In Crohn's disease
    Plosker, Greg L.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2007, 21 (02) : 125 - 132
  • [25] Adalimumab/methotrexate/prednisoneSevere COVID-19 infection: case report
    Reactions Weekly, 2021, 1836 (1) : 28 - 28
  • [26] Neutropenia in patients under treatment with clozapine and COVID-19 infection
    Bonaccorso, S.
    Ricciardi, A.
    Ouabbou, S.
    Theleritis, C.
    Ross-Michaelides, A.
    Metastasio, A.
    Stewart, N.
    Mohammed, M.
    Schifano, F.
    EUROPEAN PSYCHIATRY, 2021, 64 : S677 - S677
  • [27] Adalimumab Treatment for Hidradenitis Suppurativa Associated with Crohn's Disease
    Diamantova, Dominika
    Lomickova, Iva
    Cetkovska, Petra
    ACTA DERMATOVENEROLOGICA CROATICA, 2014, 22 (04) : 291 - 293
  • [28] Efficacy and safety of adalimumab in the treatment of Crohn's disease in children
    Manuel Navas-Lopez, Victor
    Blasco-Alonso, Javier
    Giron-Fernandez-Crehuet, Francisco
    Juliana Serrano-Nieto, Maria
    Sierra-Salinas, Carlos
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (10) : 579 - 584
  • [29] INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE
    Maas, Laura A.
    Limketkai, Berkeley N.
    Lazarev, Mark
    Melia, Joanna
    Selaru, Florin M.
    Parian, Alyssa M.
    GASTROENTEROLOGY, 2022, 162 (07) : S817 - S817
  • [30] Tuberculous monoarthritis after treatment with adalimumab in Crohn's disease
    Martinez Caselles, Alejandro
    Martinez Pascual, Cristina
    Munoz Tornero, Maria
    Sanchez Torres, Antonio
    Carballo Alvarez, Fernando
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2012, 104 (03) : 157 - 158
12345